ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975

Two Studies Advance The Treatment Of Early-Stage And Later Breast Cancer

June 27, 2008

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000

NCI advisors approve $50 million pilot for Human Cancer Genome Project; NHLBI Director Collins calls it a “unique, historic opportunity.”

November 18, 2005

Funding Opportunities: Lymphoma Foundation Offers Two-Year Fellowship Grants

July 31, 1998

In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s

November 20, 1998